-       Report 
- October 2025
-  198 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  576 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- April 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2024
-  117 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
          -       Report 
- January 2023
-  116 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
           -       Report 
- July 2024
-  96 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- July 2024
-  94 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
             The GI Stool Test market within the context of In Vitro Diagnostics is a segment of the medical diagnostics industry that focuses on the detection of gastrointestinal diseases and disorders. It is a rapidly growing market, driven by the increasing prevalence of gastrointestinal diseases and the need for early diagnosis and treatment. GI Stool Tests are used to detect a variety of gastrointestinal conditions, including bacterial infections, parasites, and inflammatory bowel disease. These tests are    typically performed in a laboratory setting and can provide valuable information to healthcare providers.
The GI Stool Test market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Quest Diagnostics, LabCorp, Bio-Rad Laboratories, and Genova Diagnostics. Other companies in the market include Eurofins Scientific, Mayo Medical Laboratories, and ARUP Laboratories. Show Less   Read more